Clinical trial

Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer

NCT01969032

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-08-01

PhasePHASE2

Study timeline

Study start (unknown)2011-08-01Date precision: month

Registry last updated2014-11-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Cancerunresolved

Interventions

Paclitaxel, Carboplatinum, Doxorubicin, Endoxan, CapecitabineDRUG

Sponsors & collaborators

Russian Academy of Medical Scienceslead sponsor

Mapped research locations

MoscowRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01969032 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.